Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0380
-0.0050 (-11.63%)
Mar 27, 2026, 2:57 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 3.39 million as of March 27, 2026. Its market cap has decreased by -54.25% in one year.
Market Cap
3.39M
Enterprise Value
9.46M
Revenue
347.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 3.39M, an increase of 8.72%. That is a compound annual growth rate of 0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.39M | -41.93% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 27.83M |
| Vitura Health | 26.51M |
| Peak Processing | 20.31M |
| IDT Australia | 19.23M |
| Cann Group | 9.58M |
| Epsilon Healthcare | 8.17M |
| ECS Botanics Holdings | 7.98M |
| Invion | 7.27M |